Format

Send to

Choose Destination
Mol Cell Proteomics. 2009 May;8(5):883-6. doi: 10.1074/mcp.R800015-MCP200. Epub 2009 Jan 7.

A human proteome detection and quantitation project.

Author information

1
The Plasma Proteome Institute, Washington, D. C. 20009, USA. leighanderson@plasmaproteome.org

Abstract

The lack of sensitive, specific, multiplexable assays for most human proteins is the major technical barrier impeding development of candidate biomarkers into clinically useful tests. Recent progress in mass spectrometry-based assays for proteotypic peptides, particularly those with specific affinity peptide enrichment, offers a systematic and economical path to comprehensive quantitative coverage of the human proteome. A complete suite of assays, e.g. two peptides from the protein product of each of the approximately 20,500 human genes (here termed the human Proteome Detection and Quantitation project), would enable rapid and systematic verification of candidate biomarkers and lay a quantitative foundation for subsequent efforts to define the larger universe of splice variants, post-translational modifications, protein-protein interactions, and tissue localization.

PMID:
19131327
PMCID:
PMC2689772
DOI:
10.1074/mcp.R800015-MCP200
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center